MRI-based cortical gray/white matter contrast in young adults who endorse psychotic experiences or are at genetic risk for psychosis.

Psychiatry Res Neuroimaging

PROMENTA Research Center, Department of Psychology, Pob 1094, Blindern, N-0317 Oslo, Forskningveien 3A, University of Oslo, Norway; Division of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.

Published: March 2025

Research has reported group-level differences in cortical grey/white matter contrast (GWC) in individuals with psychotic disorders. However, no studies to date have explored GWC in individuals at elevated risk for psychosis. In this study, we examined brain microstructure differences between young adults with psychotic-like experiences or a high genetic risk for psychosis and unaffected individuals. Moreover, we investigated the association between GWC and the number of and experiences of psychosis-like symptoms. The sample was obtained from the Avon Longitudinal Study of Parents and Children (ALSPAC): the psychotic experiences study, consisting of young adults with psychotic-like symptoms (n = 119) and unaffected individuals (n = 117), and the schizophrenia recall-by-genotype study, consisting of individuals with a high genetic risk for psychosis (n = 95) and those with low genetic risk for psychosis (n = 95). Statistical analyses were performed using FSL's Permutation Analysis of Linear Models (PALM), controlling for age and sex. The results showed no statistically significant differences in GWC between any of the groups and no significant associations between GWC and the number and experiences of psychosis-like symptoms. In conclusion, the results indicate there are no differences in GWC in individuals with high, low or no risk for psychosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2025.111981DOI Listing

Publication Analysis

Top Keywords

risk psychosis
24
genetic risk
16
young adults
12
gwc individuals
12
matter contrast
8
psychotic experiences
8
adults psychotic-like
8
high genetic
8
unaffected individuals
8
gwc number
8

Similar Publications

MRI-based cortical gray/white matter contrast in young adults who endorse psychotic experiences or are at genetic risk for psychosis.

Psychiatry Res Neuroimaging

March 2025

PROMENTA Research Center, Department of Psychology, Pob 1094, Blindern, N-0317 Oslo, Forskningveien 3A, University of Oslo, Norway; Division of Mental Health and Substance Abuse, Diakonhjemmet Hospital, Oslo, Norway.

Research has reported group-level differences in cortical grey/white matter contrast (GWC) in individuals with psychotic disorders. However, no studies to date have explored GWC in individuals at elevated risk for psychosis. In this study, we examined brain microstructure differences between young adults with psychotic-like experiences or a high genetic risk for psychosis and unaffected individuals.

View Article and Find Full Text PDF

Background: To improve early intervention and personalise treatment for individuals early on the psychosis continuum, a greater understanding of symptom dynamics is required. We address this by identifying and evaluating the movement between empirically derived attenuated psychotic symptomatic substates-clusters of symptoms that occur within individuals over time.

Methods: Data came from a 90-day daily diary study evaluating attenuated psychotic and affective symptoms.

View Article and Find Full Text PDF

Purpose Of Review: This review examines the literature associating cannabis with schizophrenia, glutamate dysregulation in schizophrenia, and cannabis involvement in glutamate pathways. Cannabis use is widespread among adolescents world-wide and is sold legally in many countries for recreational use in a variety of forms. Most people use it without lasting effects, but a portion of individuals have negative reactions that manifest in acute psychotic symptoms, and in some, symptoms continue even after the use of cannabis has ceased.

View Article and Find Full Text PDF

Corticosteroid treatment sometimes causes psychiatric side effects such as mania, depression, and psychosis. It is believed that exogenous corticosteroids lead to dysregulation of corticosteroid signaling and neurotransmitters in a dose-dependent manner. Therefore, the administration of corticosteroids is at risk of worsening bipolar disorder.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!